These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3632011)

  • 1. Should we screen for congenital adrenal hyperplasia? A review of 117 cases.
    Virdi NK; Rayner PH; Rudd BT; Green A
    Arch Dis Child; 1987 Jul; 62(7):659-62. PubMed ID: 3632011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.
    Donaldson MD; Thomas PH; Love JG; Murray GD; McNinch AW; Savage DC
    Arch Dis Child; 1994 Mar; 70(3):214-8. PubMed ID: 8135566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers?
    Murtaza L; Sibert JR; Hughes I; Balfour IC
    Arch Dis Child; 1980 Aug; 55(8):622-5. PubMed ID: 6969062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.
    Gidlöf S; Falhammar H; Thilén A; von Döbeln U; Ritzén M; Wedell A; Nordenström A
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):35-42. PubMed ID: 24622265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
    Török D; Eckhardt G; Sólyom J
    Eur J Pediatr; 2003 Dec; 162(12):844-9. PubMed ID: 14648216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.
    Hughes IA
    J Inherit Metab Dis; 1986; 9 Suppl 1():115-23. PubMed ID: 3097410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for congenital adrenal hyperplasia in Hungary].
    Sólyom J
    Orv Hetil; 1989 Sep; 130(37):1979-82, 1985-6. PubMed ID: 2780047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical features of congenital adrenal hyperplasia in Great Britain.
    Khalid JM; Oerton JM; Dezateux C; Hindmarsh PC; Kelnar CJ; Knowles RL
    Arch Dis Child; 2012 Feb; 97(2):101-6. PubMed ID: 22241917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006.
    Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
    Horm Res; 2009; 72(4):247-51. PubMed ID: 19786796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J; Hughes IA
    Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
    Held PK; Shapira SK; Hinton CF; Jones E; Hannon WH; Ojodu J
    Mol Genet Metab; 2015 Nov; 116(3):133-8. PubMed ID: 26296712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for congenital adrenal hyperplasia.
    Cacciari E; Balsamo A; Cassio A; Piazzi S; Bernardi F; Salardi S; Cicognani A; Pirazzoli P; Zappulla F; Capelli M
    Arch Dis Child; 1983 Oct; 58(10):803-6. PubMed ID: 6639129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying expression for salt losing in related patients with congenital adrenal hyperplasia.
    Rosenbloom AL; Smith DW
    Pediatrics; 1966 Aug; 38(2):215-9. PubMed ID: 5944156
    [No Abstract]   [Full Text] [Related]  

  • 16. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How reliable is newborn screening for congenital adrenal hyperplasia?
    Pass KA
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):74-5. PubMed ID: 16932259
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening.
    Nordenström A; Ahmed S; Jones J; Coleman M; Price DA; Clayton PE; Hall CM
    Horm Res; 2005; 63(1):22-8. PubMed ID: 15627780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt-losers and non salt-losers in congenital adrenal hyperplasia.
    Bartter FC
    Arch Dis Child; 1969 Feb; 44(233):138-9. PubMed ID: 4303934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.